Cargando…
Clopidogrel as a Distinctive Cause of Insulin Autoimmune Syndrome: A Systematic Case Review
The sulfhydryl group of clopidogrel metabolite could induce insulin autoimmune syndrome (IAS) with hypoglycemia as the major symptom. For patients with cardiovascular disease taking clopidogrel for vascular protection, this adverse event hypoglycemia increases the risk of cardiovascular events. Howe...
Autores principales: | Chen, Shi, Qiang, Jiaqi, Zhao, Bin, Tian, Ran, Yuan, Tao, Li, Ming, Li, Mei, Gu, Zhaoqi, Yang, Liping, Zhu, Huijuan, Pan, Hui, Tang, Yan, Li, Yuxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464827/ https://www.ncbi.nlm.nih.gov/pubmed/37649588 http://dx.doi.org/10.2147/DMSO.S418845 |
Ejemplares similares
-
Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis
por: Chen, Shi, et al.
Publicado: (2023) -
Clopidogrel-Induced Insulin Autoimmune Syndrome: A Newly Recognized Cause of Hypoglycemia in a Patient Without Diabetes
por: Rajpal, Aman, et al.
Publicado: (2017) -
Simultaneous determination of clopidogrel, 2-oxo-clopidogrel, and the thiol metabolite of clopidogrel in human plasma by LC-MS/MS
por: Xu, Lei, et al.
Publicado: (2022) -
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
por: Yi, Xingyang, et al.
Publicado: (2020) -
Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives
por: Zhang, Yan-Jiao, et al.
Publicado: (2017)